Success Stories

Projects that delivered results

Five research and development projects run with industrial partners and clinical institutes, from the probiotic strain to the finished formulation, from the human supplement to functional feed. Here you find what was done and with what result, without opening another page.

PRO-MIND

PRO-MIND

Gut-brain axis · ongoing project · funded by the Lombardy Region
The value delivered

Probiotic and prebiotic solutions for the psychological well-being of people with chronic gastrointestinal disorders such as Irritable Bowel Syndrome. The aim is to reduce reliance on conventional antidepressants, which carry adverse effects and a substantial economic burden, through a natural approach based on optimised probiotic strains acting on gut health and depressive symptoms at the same time.

What we did
  • Development and preclinical validation of the formulations on advanced experimental models
  • Groundwork for the move to clinical studies in humans
  • Comparative study of probiotics versus placebo on depressive symptoms in patients with disorders of gut-brain interaction
Partners
Università degli Studi di Milano — Dipartimento di Chimica Consorzio Italbiotec Istituto Mario Negri IRCCS San Gerardo dei Tintori Opella
Full project page
SmartNutriHealth2

SmartNutriHealth2

Healthy ageing · centre of excellence for nutraceutical research 4.0 · funded by the Lombardy Region
The value delivered

Innovative nutraceutical products for healthy ageing, supporting gut and metabolic health while modulating the immune system. The project brings together the industrial and biotechnological expertise of its partners in an innovation ecosystem, with products designed from the outset for industrialisation on global markets.

What we did
  • Development of next-generation probiotics and postbiotics
  • Development of lactoferrin-derived functional ingredients
  • Environmental and social impact analysis alongside the scientific work
Partners
Consorzio Italbiotec Opella
Full project page
Probiotiká

Probiotiká

Cholesterol and dysmetabolism · two research lines
The value delivered

Two mixtures with distinct goals: one to reduce blood cholesterol, the other for dysmetabolism. For the first, a B. reuteri mutant with increased BSHase activity was selected; for the second, efficacy was confirmed in vivo in animals, with improved healthiness and weight gain.

What we did
  • Study and characterisation of pro- and prebiotic products for the control of hypercholesterolaemia, with mixtures of microorganisms, vitamins and prebiotics
  • Selection of a B. reuteri high producer of BSHase
  • Development of a B. clausii mixture with Lactive and plant extracts for dysmetabolism
  • Isolation of an antibiotic-resistant mutant
Partners
Probiotic CGB Fondazione MultiMedica ONLUS Consorzio Interdisciplinare di Studi Biomolecolari e Applicazioni Industriali Sanofi
Full project page
SCIDA

SCIDA

IBS and atopic dermatitis · from product to clinical trial
The value delivered

A mixture of two selected plant extracts and probiotics for IBS and atopic dermatitis, with confirmation of its antioxidant, prebiotic and anti-inflammatory properties and an assessment of stability. The project went all the way to a clinical trial with microbiome analysis, collecting enough data for scientific publication and patenting.

What we did
  • Definition and optimisation of the pre- and probiotic mixture, focused on the anti-inflammatory effect
  • Clinical trial with analysis of the volunteers’ gut microbiome before and after taking the product, using Illumina technology
  • Formulation in sachets and capsules to assess stability over time and set up industrialisation
Partners
Università degli Studi di Milano — Dipartimento di Chimica Consorzio Italbiotec ASST Fatebenefratelli Sacco Sanofi Roelmi HPC
Full project page
InnoFeed

InnoFeed

Animal nutrition · tyndallised microorganisms as a prebiotic raw material
The value delivered

Products based on selected, heat-inactivated (tyndallised) microorganisms, usable as a raw material with prebiotic properties for animal nutrition. The best formulation was identified by balancing efficacy and cost, and efficacy was confirmed by in vivo trials on piglets, administering the mixture in the feed.

What we did
  • Optimisation of the microorganism tyndallisation processes
  • Definition of the formulation on calibrated percentages of microorganisms and mannan-oligosaccharides (MOS)
  • Measurement of the prebiotic index and selection of the best mixture
  • In vivo trials on piglets with administration in the feed
Areas involved
Full project page
You develop an ingredient and you want evidence your customers can use Ingredient validation
You develop a finished product and you want to know what stays active in the formulation Supplement valorisation

Shall we talk about it?

Tell us about the product and what you need to show: we will tell you which models and which tests the case calls for.

Write to us

Tell us about your project

Write to us here: the division team will get back to you.